Form 4: Life360 Director John Coghlan Executes Stock Sale Under 10b5-1 Plan

Director John Coghlan sold 3,125 shares of Life360 stock at an average price of $37.86, executed under a pre-arranged 10b5-1 trading plan.

Summary

• On April 1, 2025, John Coghlan, a director at Life360, sold 3,125 shares of common stock at a weighted average price of $37.86.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 6, 2024.
• Following the transaction, Coghlan directly owns 3,484 shares and indirectly owns 64,834 shares through The John Philip Coghlan 2024 Grantor Retained Annuity Trust and 34,286 shares through the John Coghlan Living Trust.
• Coghlan also transferred 1,742 directly held shares to the John Coghlan Living Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document reports a routine stock sale by a director under a pre-arranged trading plan. There's no indication of positive or negative sentiment towards the company's prospects.

Positives

• The sale was conducted under a pre-arranged 10b5-1 trading plan, indicating it was planned in advance and not based on current, non-public information.

Industry Context

Sales by insiders are common and often pre-planned, but investors may scrutinize the timing and volume of sales for potential insights into management's view of the company's prospects.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a common practice among corporate insiders to sell shares over time, mitigating concerns about trading on non-public information.
• The volume of shares sold is relatively small compared to the total outstanding shares of Life360, suggesting it's unlikely to have a significant impact on the stock price.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, but the pre-arranged nature of the sale mitigates concerns about insider trading.

Key Dates

Keywords

Life360, John Coghlan, Form 4, Stock Sale, 10b5-1 Trading Plan, Director, Beneficial Ownership